Clinical Trials Logo

Clinical Trial Summary

This study will implement a peer navigation intervention to improve linkage to and retention in HIV care for inmates released from L.A. county jail into the community.


Clinical Trial Description

The proposed study has two Primary Specific Aims: 1. To examine individual-level and structural-level barriers to HIV care after release from jail, using formative semi-structured interviews with ex-inmates, case managers, and HIV care providers; and to use the information we obtain to inform the adaptation and tailoring of an intervention designed to improve linkage with and retention to HIV care for HIV+ ex-inmates (Complete); 2. Using a two-group experimental RCT design, to test the adapted peer navigation intervention condition for HIV+ inmates upon release from jail compared to a usual care condition, and to evaluate the intervention's effectiveness at improving linkage with and retention in HIV care, self-reported ART adherence, and HIV RNA viral load suppression; The intervention is hypothesized to result in greater linkage to care, a greater proportion completing at least three HIV care visits per year, increased self-reported ART adherence, and decreased levels of HIV RNA viral load compared to the usual care control group. Secondary Aims of the study include assessing the potential moderating effects of substance abuse, the potential mediating effects of substance abuse treatment, and the program's effects on recidivism, and costs. Active substance abuse is hypothesized to moderate the effect of the intervention, such that the intervention will be less effective among participants who report substance use. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01406626
Study type Interventional
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date December 2012
Completion date October 2016

See also
  Status Clinical Trial Phase
Completed NCT00787696 - Healthy Teen Girls: HIV Risk Reduction Phase 1/Phase 2
Completed NCT03403569 - Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection Phase 3
Completed NCT02433743 - Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA N/A
Recruiting NCT02753049 - Adherence Connection for Counseling, Education, and Support N/A
Completed NCT01360762 - Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study Phase 3
Recruiting NCT03147859 - Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection Phase 2
Recruiting NCT04297488 - Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection N/A
Completed NCT01827540 - Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam Phase 1
Completed NCT01475890 - Vitamin D Supplementation in HIV Phase 2/Phase 3
Recruiting NCT05947539 - Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention N/A
Withdrawn NCT01442428 - Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Phase 2/Phase 3
Completed NCT02496793 - Community-Based Peer Facilitator Intervention (Zimbabwe) N/A
Completed NCT03069235 - Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program N/A
Completed NCT03794648 - The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication N/A
Withdrawn NCT04183738 - Inflammation and Co-Infections in D²EFT Phase 4
Enrolling by invitation NCT03919695 - Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda N/A
Recruiting NCT04215926 - NAFLD in HIV-infected Patients
Completed NCT04371835 - COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings
Completed NCT01140633 - Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda N/A
Enrolling by invitation NCT04373551 - WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP) N/A